Lumibird
10.45
09-January-25 10:51:08
15 minutes delayed
Stocks
-0.05
-0.48%
Today's range
10.30 - 10.45
ISIN
FR0000038242
Source
Cboe
-
Lumibird : nombre de droits de vote et d'actions au 30 novembre 2024
09 Dec 2024 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION
27 Nov 2024 02:00:00 By Nasdaq GlobeNewswire
-
21 Oct 2024 11:55:15 By Nasdaq GlobeNewswire
-
LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S STRATEGY WITH FINANCING OF OVER €100M
15 Oct 2024 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: FIRST-HALF RESULTS FOR 2024 UP IN THE MEDICAL DIVISION, LOWER IN THE PHOTONICS DIVISION
24 Sep 2024 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD RECEIVES NEW ORDERS FROM THALES
24 Jul 2024 11:35:00 By Nasdaq GlobeNewswire
-
22 Jul 2024 11:50:17 By Nasdaq GlobeNewswire
-
LUMIBIRD PRESENTS ITS NEW STRATEGIC PLAN
22 May 2024 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A PLATFORM TO HELP DIAGNOSE DRY EYE
03 May 2024 01:30:00 By Nasdaq GlobeNewswire
-
05 Apr 2024 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2024
25 Mar 2024 12:45:00 By Nasdaq GlobeNewswire
-
12 Mar 2024 12:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR CV90
29 Feb 2024 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: 2023 REVENUES AT €203.6M
29 Jan 2024 11:46:50 By Nasdaq GlobeNewswire
-
LUMIBIRD: FINANCIAL COMMUNICATIONS AGENDA
26 Jan 2024 10:10:00 By Nasdaq GlobeNewswire
-
LUMIBIRD ADJUSTS ITS 2023 GROWTH TARGET
14 Dec 2023 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD CLARIFIES ITS INTENTIONS REGARDING CILAS
24 Nov 2023 02:00:00 By Nasdaq GlobeNewswire
-
15 Nov 2023 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: REVENUES FOR THE FIRST 9 MONTHS OF 2023: €139.0M (+11%)
24 Oct 2023 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: 2023 HALF-YEAR EARNINGS
26 Sep 2023 11:45:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >